VC firm
Empactful Capital
Also known as Empactful Capital Fund II, L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-20Source (opens in a new tab)
- Headquarters
- DOYLESTOWN, PA, United States
- Founded
- 2016
- Assets under management
- $63.2MForm ADV private fund GAV, as of 2026-02-25Source (opens in a new tab)
- Latest fund size
- $30.7MSEC amount sold, as of 2022-11-22Source (opens in a new tab)
- Funds
- 2
- Check size
- We write $1-7M checksSource (opens in a new tab)
- Legal name
- EMPACTFUL CAPITAL LLC
Claim, correct or request removal
Record updated 30 September 2026
About
We are a group of healthcare market leaders and entrepreneurs investing in proven, rapidly growing technology companies that enable incumbent organizations to take advantage of key strategic opportunities and solve the most financially pressing problems in healthcare.
Investment approach
- Thesis
- We recognize that healthcare is highly fragmented, with misaligned incentives that often impede the delivery of high-quality care. We focus our investments on technology companies aligned with our core pillars.Source (opens in a new tab)
- Leads rounds
- Yes
- Lead policy
- We write $1-7M checks and typically act as a lead inve
- Eligibility
- We are focused on companies with proprietary technology and differentiated IP. We lean towards SaaS models but also invest in tech-enabled services.
- Traction requirement
- Our sweet spot is $3-10M ARR.
- Investing status notes
- Empactful Capital invests in companies with proven technologies that improve healthcare efficiencies, long-term viability and patient experience.
Funds
- Empactful Capital Fund II, L.P.
- $30.7MVintage 2022, Main fund, SEC amount sold
- EMPACTFUL CAPITAL FUND I LLC
- Main fund
SEC registration
- Registered adviser
- EMPACTFUL CAPITAL LLC
- CRD number
- 325002 (opens in a new tab)
- SEC file number
- 802-127372
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $63.2Mas of 2026-02-25
- Private funds reported
- 2
- Principal office
- DOYLESTOWN, PA, United States
- SEC CIK
- 1948185
Loading relationship preview